Molecular IP
Intellectual Property for Life Sciences, Chemistry and Biotechnology

By: Steven M. Kellner In Novartis AG v. Torrent Pharms. Ltd., No. 2016-1352, 2017 U.S. App. LEXIS 6245 (Fed. Cir. Apr. 12, 2017), the Federal Circuit affirmed the Patent Trial and Appeal… read more

By Danielle C. Froschhauser In Eli Lilly & Co. v. Teva Parenteral Medicines, Inc., the Federal Circuit affirmed the district court’s finding of infringement where two actors perform individual steps… read more

By Marina Sigareva, Ph.D. On February 22, 2017, the Supreme Court reversed the Federal Circuit’s decision in Promega Corp. v. Life Technologies Corp. holding that supplying a single component of… read more

By Ryan W. O’Donnell On January 3, 2017, the United States Court of Appeals for the Federal Circuit (CAFC) affirmed a decision of the Patent Trial and Appeals Board (PTAB)… read more